An open-label phase 1 study to evaluate relative bioavailability of H3B-6545 (tablet formulation compared to capsules) and effect of pantoprazole on pharmacokinetics of H3B-6545 in healthy post-menopausal women
Latest Information Update: 16 Jul 2021
At a glance
- Drugs H3B-6545 (Primary) ; Pantoprazole
- Indications Breast cancer
- Focus Pharmacokinetics
- 16 Jul 2021 New trial record
- 08 Jun 2021 Results presented at the 57th Annual Meeting of the American Society of Clinical Oncology